Journal of Substance Abuse Treatment
Volume 38, Issue 2 , Pages 153-159 , March 2010

Home- versus office-based buprenorphine inductions for opioid-dependent patients

  • Nancy L. Sohler, Ph.D., M.P.H.

      Affiliations

    • Sophie Davis School of Biomedical Education, Community Health and Social Medicine, City College of the City University of New York, NY 10031, USA
    • Montefiore Medical Center and the Albert Einstein College of Medicine, Department of Epidemiology and Population Health, Bronx, NY 10467, USA
    • Montefiore Medical Center and the Albert Einstein College of Medicine, Department of Family and Social Medicine, Bronx, NY 10467, USA
    • Corresponding Author InformationCorresponding author. Sophie Davis School of Biomedical Education, City College of the CUNY, 160 Convent Avenue, Harris Hall, Room 400, New York, NY 10031, USA. Tel.: +1 212 650 7786; fax: +1 212 650 7778.
  • ,
  • Xuan Li, M.S.

      Affiliations

    • Montefiore Medical Center and the Albert Einstein College of Medicine, Division of General Internal Medicine, Bronx, NY 10467, USA
  • ,
  • Hillary V. Kunins, M.D., M.P.H., M.S.

      Affiliations

    • Montefiore Medical Center and the Albert Einstein College of Medicine, Department of Family and Social Medicine, Bronx, NY 10467, USA
    • Montefiore Medical Center and the Albert Einstein College of Medicine, Division of General Internal Medicine, Bronx, NY 10467, USA
  • ,
  • Galit Sacajiu, M.D., M.P.H.

      Affiliations

    • Montefiore Medical Center and the Albert Einstein College of Medicine, Department of Family and Social Medicine, Bronx, NY 10467, USA
    • Montefiore Medical Center and the Albert Einstein College of Medicine, Division of General Internal Medicine, Bronx, NY 10467, USA
  • ,
  • Angela Giovanniello, PharmD.

      Affiliations

    • Montefiore Medical Center and the Albert Einstein College of Medicine, Department of Family and Social Medicine, Bronx, NY 10467, USA
  • ,
  • Susan Whitley, M.D.

      Affiliations

    • Bellevue Hospital Center, Opioid Addiction Treatment Program, New York, NY 10016, USA
  • ,
  • Chinazo O. Cunningham, M.D., M.S.

      Affiliations

    • Montefiore Medical Center and the Albert Einstein College of Medicine, Department of Family and Social Medicine, Bronx, NY 10467, USA
    • Montefiore Medical Center and the Albert Einstein College of Medicine, Division of General Internal Medicine, Bronx, NY 10467, USA

Received 12 May 2009 ,Revised 31 July 2009 ,Accepted 4 August 2009.

References 

  1. Alford DP, LaBelle CT, Richardson JM, O'Connell JJ, Hohl CA, Cheng DM, et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. Journal of General Internal Medicine. 2007;22:171–176
  2. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469–2475
  3. Center for Substance Abuse Treatment . Clinical guidelines for the uses of buprenorphine in the treatment of opioid addiction. Treatment Improvement Protocol (TIP) series 40. DHHS Publication No. (SMA) 04-3939. 2004;Rockville, MD
  4. Cunningham C, Giovanniello A, Sacajiu G, Whitley S, Mund P, Beil R, et al. Buprenorphine treatment in an urban community health center: What to expect. Family Medicine. 2008;40:500–506
  5. Drug Addiction Treatment Act of 2000. Public Law 106–210.
  6. Fiellin DA, Pantalon MV, Pakes JP, O'Connor PG, Chawarski M, Schottenfeld RS. Treatment of heroin dependence with buprenorphine in primary care. American Journal of Drug and Alcohol Abuse. 2002;28:231–241
  7. Frank B. An overview of heroin trends in New York City: Past, present and future. Mt. Sinai Journal of Medicine. 2000;67:340–346
  8. Hibbard JH, Cunningham PJ. How engaged are consumers in their health and health care, and why does it matter?. Research Briefs. 2008;8:1–9
  9. Lee JD, Grossman E, DiRocco D, Gourevitch MN. Home buprenorphine/naloxone induction in primary care. Journal of General Internal Medicine. 2008;24:226–232
  10. Lorig KR, Ritter P, Stewart AL, Sobel DS, Brown BW, Bandura A, et al. Chronic disease self-management program: 2-Year health status and health care utilization outcomes. Medical Care. 2001;39:1217–1223
  11. Lorig KR, Sobel DS, Stewart AL. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: A randomized trial. Medical Care. 1999;37:5–14
  12. McEvoy P, Barnes P. Using the chronic care model to tackle depression among older adults who have long-term physical conditions. Journal of Psychiatric Mental Health Nursing. 2007;14:233–238
  13. Mintzer IL, Eisenberg M, Terra M, MacVane C, Himmelstein DU, Woolhandler S. Treating opioid addiction with buprenorphine–naloxone in community-based primary care settings. Annals of Family Medicine. 2007;5:146–150
  14. Mosen DM, Schmittdiel J, Hibbard J, Sobel D, Remmers C, Bellows J. Is patient activation associated with outcomes of care for adults with chronic conditions?. Journal of Ambulatory Care Management. 2007;30:21–29
  15. New York City Department of Health and Mental Hygiene. (2008). Buprenorphine Initiative. Accessed on 2/12/08 at http://home2.nyc.gov/html/doh/downloads/pdf/basas/presentation-buprenorphine.pdf
  16. O'Connor PG, Oliveto AH, Shi JM, Triffleman EG, Carroll KM, Kosten TR, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine. 1998;105:100–105
  17. Stein MD, Cioe P, Friedmann PD. Buprenorphine retention in primary care. Journal of General Internal Medicine. 2005;20:1038–1041
  18. Street RL, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: Why some patients are more involved than others. Medical Care. 2005;43:960–999
  19. Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, et al. A trial of integrated buprenorphine/naloxone and HIV clinical care. Clinical Infectious Diseases. 2006;43:S184–S190
  20. Tobias C, Cunningham WE, Cunningham CO, Pounds MB. AIDS Patient Care & STDs. 2007;21:S3–S8
  21. Wagner EH. Chronic disease management: What will it take to improve care for chronic illness?. Effective Clinical Practice. 1998;1:2–4
  22. Wagner EH, Austin BR, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care translating evidence into action. Health Affairs. 2001;20:64–78
  23. Watkins K, Pincus HA, Tanielian TL, Lloyd J. Using the chronic care model to improve treatment of alcohol use disorders in primary care settings. Journal of Studies on Alcohol. 2003;64:209–218

PII: S0740-5472(09)00124-X

doi: 10.1016/j.jsat.2009.08.001

Journal of Substance Abuse Treatment
Volume 38, Issue 2 , Pages 153-159 , March 2010